Molecular and cellular evidence for hsa‐miR‐1254 suppressor effect against HER2 signaling in breast cancer

MiR-1254 inhibits proliferation, migration and invasion of human brain tumour cell lines

(2018) Gang Li et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer

(2018) Xin Li et al.   Molecular Cancer

Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma

(2018) Dong Jiang et al.   Cell Death & Disease

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine

(2017) Bethany Smith et al.   ENDOCRINE-RELATED CANCER

CCAR1 5′ UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance

(2016) Gaopeng Li et al.   CELL RESEARCH

Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS–p110 crosstalk

(2016) Rastislav Tamaskovic et al.   Nature Communications

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer

(2016) Robert Lesurf et al.   Cell Reports

PTENInhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERTPathway in Lung Adenocarcinoma A549 Cells

(2016) Xiao-Xiao Lu et al.   Biomed Research International

HER2 expression status in diverse cancers: review of results from 37,992 patients

(2015) Min Yan et al.   CANCER AND METASTASIS REVIEWS

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

(2015) M. I. Del Principe et al.   HAEMATOLOGICA

Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer

(2015) Xin Li et al.   INTERNATIONAL JOURNAL OF CANCER

CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo

(2015) Nicole Mende et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis

(2015) Camilo Garay et al.   MOLECULAR BIOLOGY OF THE CELL

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

(2015) M. I. Del Principe et al.   HAEMATOLOGICA

PI3K/Akt-mediated regulation of p53 in cancer

(2014) Aswin G. Abraham et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

(2014) Christopher J. Cheng et al.   NATURE

Molecular classification of breast cancer

(2014) Darina Vuong et al.   VIRCHOWS ARCHIV

Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis

(2013) Claire Josse et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

(2013) Diana P. English et al.   Molecular Diagnosis & Therapy

The ErbB/HER family of protein-tyrosine kinases and cancer

(2013) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics

(2011) Jean-Claude Martinou et al.   DEVELOPMENTAL CELL

A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

(2011) A. Bertotti et al.   Cancer Discovery

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

(2010) C.-C. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA